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Volume 57, Number 6 Abstracts 1721individuals (Brady AR et al, Circulation 2004;110:16-21). Various groups
have recommended different intervals between ultrasound screenings of
patients with AAAs, with these intervals largely dependent on aneurysm
diameter. There is, however, no consensus regarding the optimal time
between ultrasound examinations in patients with small AAAs. In this study,
the authors sought to determine the rates at which small AAAs progress to
reach a threshold diameter of 5.5 cm and also to determine the risk of AAA
rupture over time. Using these data, they hope to develop more scientiﬁcally
based recommendations to guide AAA surveillance protocols. The authors
identiﬁed, through a systematic literature review, studies with individual
patient data recording AAA growth and rupture. Original study authors
were contacted. The authors identiﬁed 18 data sets that provided repeat
ultrasound measurements of AAA diameter over time in 15,471 patients.
AAA diameters were analyzed using a random-effects model accounting
for between-patient variability in size and growth rates of AAA. Rupture
rates were analyzed by proportional hazard regression using the model
AAA diameter as a time-varying covariant. Predictions of the risk of growing
to a diameter >5.5 cm and of rupture within given time intervals were esti-
mated and pooled across studies by random effects meta-analysis. Variation
in AAA growth and rupture rates varied considerably among studies. For
each 0.5-cm increase in AAA diameter, growth rates increased on average
0.59 mm/y (95% conﬁdence interval [CI], 0.51-0.66 mm/y). Rupture
rates increased by a factor of 1.91 (95% CI, 1.61-2.25). As an example,
to monitor the AAA growth risk in men to >5.5 cm to <10%, on average,
a 7.4-year surveillance interval (95% CI, 6.7-8.1 years) is sufﬁcient for a 3-
cm AAA. However, an 8-month interval (95% CI, 7-10 months) is necessary
for a 5-cm AAA. To control the risk of rupture in men to <1%, the corre-
sponding estimated surveillance intervals are 8.5 years (95% CI, 7.0-10.5
years) and 17 months (95% CI, 14-22 months).
Comment: The recommendations derived from this meta-analysis are
considerably at odds with the Society for Vascular Surgery recommenda-
tions for surveillance of a small AAAs (Chaikof EL et al, J Vasc Surg
2009;50(4 Suppl):S2-49). The authors point out that if one acknowledges
populations from each study analyzed may have different growth and
rupture rates and applies the 95% prediction limits of the estimates of the
studies to determine optimal surveillance intervals, surveillance intervals
for men could be reduced to once every 2 years for AAAs measuring 3.0
to 3.9 cm and once yearly for those 4.0 to 4.9 cm, with surveillance scans
every 6 months for aneurysms between 5.0 and 5.4 cm. This could poten-
tially reduce the average number of surveillance scans required for an AAA
measuring 3 cm fromw15 to 10. The authors also point out there is a need
for additional research with respect to women with aneurysms in the range
of 4.5 to 5.4 cm. Although rupture rates are higher in women with smaller
AAAs, mortality of surgery is also higher. Determination of the most cost-
effective surveillance intervals for men and women is clearly an active area
of aneurysm-related research.Aortic Rupture and Sac Expansion After Endovascular Repair of
Abdominal Aortic Aneurysm
Holt PJ, KarthikesalingamA, Patterson BO, et al. Br J Surg 2012;99:1637-64.
Conclusion: Compared with early controlled trials and data from
image repositories, endovascular aneurysm repair (EVAR) had a lower aneu-
rysm-related mortality rate and lower sac expansion rate.
Summary: The long-term incidence, as reported by the EVAR-1
trial, of aneurysm-related mortality and rupture after EVAR of abdominal
aortic aneurysm (AAA) is higher than anticipated (Wyss TR et al, Ann
Surg 2010;252:805-12). In addition, analysis of image repositories has
suggested an alarming portion of patients undergoing EVAR may have
continued AAA sac expansion after 5 years (Schanzer A et al, Circulation
2011;123:2848-55). In the current study, the authors used modern
reporting standards and 3-dimensional morphologic analysis to report
a contemporary series of clinical outcomes after EVAR. They postulate
increased expertise in endograft technology, case selection, and post-
operative reintervention have improved outcomes over previous long-
term reports of EVAR efﬁcacy. They prospectively analyzed patients
undergoing infrarenal EVAR between 2004 and 2010. Compliance
with manufactures’ instructions for use (IFU) was established using
three-dimentional computed tomography. Primary outcome measures
were all-cause and aneurysm-related mortality, postoperative rupture,
reintervention, and sac expansion. Adverse events were reported with
Kaplan-Meier survival analysis, with the log-rank test used to compare
procedures within or outside IFU. The study comprised 478 patients
with a median age of 76 years and a median AAA diameter of 62.9
mm. Median follow-up was 44 months (range, 11-94 months). In 198
patients (41.4%), implantation of the endografts was compliant with the
IFU. The 30-day mortality was 2.1%. Surgery was elective in 445 patients
and nonelective in 23. Aneurysm-related mortality was 0.897 deaths for
100 person-years, and all-cause mortality was 8.558 deaths per 100
person-years. There was signiﬁcantly lower survival outside IFU (P ¼
.012). Only two patients had a late rupture (0.138/100 person-years).
One of these patients died. There were 6.12 reinterventions/100
person-years, with no difference for AAAs treated outside the IFU (P
¼ .136). Primary sac expansion occurred in 6.721/100 person-years
and secondary sac expansion in 4.142/100 person-years.
Comment: The authors report a relatively similar sac expansion rate at
5 years, as did Schanzer et al (32% vs 41%). However, sac expansion in this
study did not appear to be associated with whether the endograft procedure
was performed in compliance with IFU. Although cause of death was not
conﬁrmed by autopsy in all cases in this series, late aneurysm rupture
appeared infrequent. Therefore, there appears to be somewhat of a discon-
nect between sac expansion as an end point and aneurysm rupture as an end
point to evaluate efﬁcacy of EVAR.
